{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-109529","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2024-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.605490+00:00","generated_at":"2026-05-29T02:21:07.578908+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NeuroOne FY2024 product revenue $3.5M (+77%); FY2025 guidance $8-10M (+132-190%)","bullets":["Product revenue FY2024 $3.5M (+77% YoY); net loss $12.3M vs $11.9M prior year.","FY2025 product revenue guidance $8-10M (+132-190%); gross margin 47-51% vs 31% in FY2024.","Received $3M upfront from expanded Zimmer Biomet distribution agreement in Nov 2024; terminated $3M credit facility.","Net loss Q4 $3.3M vs $3.1M; operating expenses down 12% to $3.0M in Q4.","Nasdaq compliance: monitoring bid price until Jan 7, 2025; equity restored above $2.5M after Zimmer payment."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-109529","json":"https://secwatch.observer/filing/0001213900-24-109529.json","markdown":"https://secwatch.observer/filing/0001213900-24-109529.md","text":"https://secwatch.observer/filing/0001213900-24-109529.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024109529/0001213900-24-109529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024109529/ea0224944-8k_neuro.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:21:07.578908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}